New insider Shankar Hariharan claimed ownership of 97,087 shares (SEC Form 3)
$MEDS
Other Pharmaceuticals
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 07/25/2024 |
3. Issuer Name and Ticker or Trading Symbol
TRxADE HEALTH, INC [ MEDS ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock, par value $0.00001(1) | 81,863 | D | |
| Common Stock, par value $0.00001(1) | 15,224 | I | By spouse |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Series X Non-Voting Convertible Preferred Stock(1) | (2) | (2) | Common Stock | 1,916,816 | $0 | D | |
| Series X Non-Voting Convertible Preferred Stock(1) | (2) | (2) | Common Stock | 356,480 | $0 | I | By spouse |
| Explanation of Responses: |
| 1. These securities of TRxADE HEALTH, INC. (the "Issuer") were issued in connection with the closing of the acquisition of Scienture, Inc. ("Scienture") by the Issuer on July 25, 2024 (the "Merger") pursuant to an Agreement and Plan of Merger entered into by the Issuer, certain subsidiaries of the Issuer, and Scienture (the "Merger Agreement"). |
| 2. These shares of the Issuer's Series X Non-Voting Convertible Preferred Stock, par value $0.00001 per share (the "Preferred Stock"), have no expiration date. On the 20th calendar day following the mailing of an information statement on Schedule 14C that the Issuer is filing with the Securities and Exchange Commission and mailing to its stockholders in connection with the closing of the Merger, these shares of Preferred Stock will automatically convert on a 1-for-1 basis into fully paid and nonassessable shares of the Issuer's common stock, par value $0.00001. |
| Remarks: |
| Exhibit List - Exhibit 24.1: Power of Attorney (Shankar Hariharan) |
| /s/ Louis Kern as attorney-in-fact for Shankar Hariharan | 08/05/2024 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||